Livforsakringsbolaget Skandia Omsesidigt purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 24,231 shares of the company's stock, valued at approximately $9,445,000.
Several other hedge funds have also modified their holdings of the business. Rakuten Investment Management Inc. purchased a new stake in shares of HCA Healthcare in the second quarter valued at approximately $9,992,000. RB Capital Management LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth $1,115,000. Glenview Trust Co acquired a new stake in shares of HCA Healthcare in the second quarter valued at about $494,000. Empowered Funds LLC acquired a new position in HCA Healthcare during the second quarter worth about $9,426,000. Finally, United Capital Financial Advisors LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter worth approximately $1,983,000. 62.73% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
HCA has been the subject of several research reports. Robert W. Baird cut their price target on HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating for the company in a research note on Monday, July 27th. The Goldman Sachs Group cut their price objective on HCA Healthcare from $558.00 to $485.00 and set a "buy" rating for the company in a research report on Tuesday, July 28th. Barclays dropped their price target on HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating for the company in a research report on Monday, July 27th. Mizuho cut their target price on shares of HCA Healthcare from $525.00 to $475.00 and set an "outperform" rating for the company in a research note on Tuesday, July 28th. Finally, Truist Financial lowered their target price on shares of HCA Healthcare from $535.00 to $495.00 and set a "buy" rating for the company in a research note on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $462.64.
Get Our Latest Analysis on HCA
HCA Healthcare Price Performance
Shares of HCA stock opened at $417.57 on Friday. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The firm's 50-day simple moving average is $401.08 and its 200-day simple moving average is $441.46. The firm has a market cap of $90.40 billion, a P/E ratio of 13.98, a PEG ratio of 1.46 and a beta of 1.10.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion during the quarter, compared to analysts' expectations of $19.76 billion. During the same period in the previous year, the company earned $6.84 EPS. The business's quarterly revenue was up 8.7% compared to the same quarter last year. Analysts expect that HCA Healthcare, Inc. will post 29.42 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 10.45%.
About HCA Healthcare
(
Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
